WHY THE NAME: WHOLE BODY BRAIN

Maybe you arrived here the same way I did — not through a search for "brain health tips," but through watching someone you love lose themselves slowly, and wondering, quietly, what that means for you.

That's where this work started for me. My grandmother lived with Alzheimer's for twenty-two years. She moved in with my mother and me when I was a teenager, and my mom cared for her for sixteen of those years. I've seen what long-term caregiving looks like up close — the love and the grief running alongside each other for years, the way a disease like that reshapes an entire household. My mom's sister died of Alzheimer's in her late sixties. My uncle is currently in the end stages of the disease. And when my mom and I both learned we carry APOE4 — the gene most strongly associated with late-onset Alzheimer's — this stopped being something I studied from a distance.

I want to say something right here, because I know how that paragraph lands: it is not an ending. It is, in a lot of ways, where the real work begins.

Before I explain what this channel is about, let me tell you who I am.

I came to nutrition science through my own health, the way a lot of us do. In 2013, I was trying to resolve persistent acid reflux and got completely hooked. I went back to school and earned my master's degree in Human Nutrition and Functional Medicine. I spent over eight years as a lead instructor at the Nutritional Therapy Association, teaching health practitioners how the body works and how nutrition shapes that work. I'm also certified through Apollo Health in the PreCODE and ReCODE protocols — the clinical program built on Dr. Dale Bredesen's research on Alzheimer's prevention and reversal.

I have a deep respect for Western medicine and the scientific method. I'm not here to position myself against conventional medicine or to suggest there are secrets being kept from you. What I want to do is bridge: bring the rigor of peer-reviewed science into conversation with the preventative, root-cause thinking that mainstream medicine has been slower to adopt.

So why is this channel called Whole Body Brain?

Because the most effective strategies for protecting the brain don't target the brain directly. That's not a provocative claim — it's what the Alzheimer's prevention research keeps showing, and it changes how you think about this entire field.

A few examples that tend to surprise people.

Hearing aids. The 2024 Lancet Commission on dementia prevention identified untreated hearing loss as one of the largest single modifiable risk factors for Alzheimer's — tied for the highest population-attributable fraction on the entire list. Not a nootropic. Not a brain-training app. A hearing aid. The reason is that when the brain receives degraded auditory input over years, it quietly recruits cognitive resources to fill the gaps — resources that would otherwise go toward memory, attention, and executive function. The brain isn't being protected. It's being slowly depleted.

Blood pressure. Midlife hypertension — roughly between the ages of 40 and 65 — is one of the most consistently identified predictors of late-life cognitive outcomes. Chronic elevated pressure damages the small blood vessels in the brain over time, reducing blood flow to regions critical for memory and cognition. What harms the cardiovascular system harms the brain, often silently, decades before symptoms appear.

Blood glucose and insulin. Some researchers call Alzheimer's "Type 3 diabetes" — a phrase that oversimplifies, but that is pointing at something real. The brain is exquisitely sensitive to insulin signaling. Neurons use insulin to regulate energy metabolism, support synaptic function, and manage inflammation. Chronic insulin resistance impairs the brain's ability to use glucose effectively, increases neuroinflammation, and is associated with the pathological changes that characterize Alzheimer's disease. Metabolic health and brain health share so much biology that they can't be cleanly separated.

What these examples have in common is that none of them are brain-specific. They're cardiovascular, sensory, metabolic. They work on the brain because the brain is embedded in — and wholly dependent on — the body that houses it. That's not a metaphor. It's the biology.

This is what Whole Body Brain means. Not as a brand identity, but as an accurate description of how the research works.

There's a broader point worth making here as well. Most people who come to this topic carry some version of a belief that Alzheimer's is genetic and therefore out of their hands. That belief is understandable, and the science has moved significantly away from it. The 2024 Lancet Commission found that up to 45 percent of Alzheimer's and related cognitive decline cases worldwide could potentially be prevented or delayed by addressing modifiable risk factors. That finding doesn't eliminate genetic risk, and it isn't a guarantee for any individual. But it means there is somewhere to stand, and that somewhere is where this channel lives.

Over the coming months, we'll work through the science together: what we know about genetic risk and what it does and doesn't mean for individuals, the Bredesen protocol in detail, and the fourteen modifiable risk factors from the Lancet Commission one by one. The content is for people who want to take the evidence seriously — particularly women in midlife and later life who have watched a parent or grandparent decline and are asking what they can actually do. The question you're asking is the right question.

If you carry APOE4, I've built a course specifically for people who want to understand that gene and develop a thoughtful, evidence-based response to it. If you're ready to work one-on-one on implementing the Bredesen protocol, I offer that as well. But there's no urgency here. Start with the content. Take what's useful.

Welcome to Whole Body Brain.

References:
Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 2024;404:572-628.
de la Monte SM, Wands JR. Alzheimer's disease is type 3 diabetes — evidence reviewed. J Diabetes Sci Technol. 2008;2(6):1101-1113.